Skip to main content
Premium Trial:

Request an Annual Quote

FDA Open to Suggestions for Overcoming Drug Development Obstacles

NEW YORK, April 22 (GenomeWeb News) - The US Food and Drug Administration has established a public docket to obtain information on the major hurdles in drug, device, and biologic development, and to solicit proposed solutions.

 

The docket encourages input from industry, patients, academics, investors, and all other interested parties to be submitted via letter or electronically by July 30. All submitted material will be publicly available.

 

The FDA first outlined the initiative in a March 16 white paper that noted a decline in the number of new drug, biologic, and medical device applications, despite the recent boom in genomics, proteomics, bioinformatics and related technologies.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.